Literature DB >> 23001546

Reduced plasma ghrelin levels on day 1 after esophagectomy: a new predictor of prolonged systemic inflammatory response syndrome.

Kazuyoshi Yamamoto1, Shuji Takiguchi, Hiroshi Miyata, Yasuhiro Miyazaki, Yuichiro Hiura, Makoto Yamasaki, Kiyokazu Nakajima, Yoshiyuki Fujiwara, Masaki Mori, Kenji Kangawa, Yuichiro Doki.   

Abstract

BACKGROUND AND
PURPOSE: Ghrelin, a stomach-derived hormone, stimulates growth hormone secretion and appetite, and inhibits excessive inflammatory response. Plasma ghrelin might affect the inflammatory response to stressful surgical interventions. The aim of this study was to investigate the relationship between serial changes in plasma ghrelin concentrations and the postoperative clinical course after esophagectomy.
METHODS: The prospective cohort study subjects were 20 patients with esophageal cancer, who underwent esophagectomy with gastric tube reconstruction. Blood samples were taken six times perioperatively during the course of esophagectomy.
RESULTS: The plasma ghrelin level decreased to 33 % (range 15-90 %) on postoperative day (POD) 1, relative to the preoperative level, then recovered to about 50 % by POD 3-10. The duration of systemic inflammatory response syndrome (SIRS) was significantly longer in patients with a marked ghrelin reduction to <33 % on POD 1, than in those with less marked reduction of ≥ 33 % (6.1 ± 1.3 vs. 2.1 ± 0.6 days, P = 0.019). On POD 1, the only inflammatory marker that correlated with the duration of SIRS was the % ghrelin, whereas C-reactive protein, leukocyte count, and IL-6 did not.
CONCLUSION: An early postoperative drop in plasma ghrelin correlated with prolonged SIRS after esophagectomy. Thus, the supplementation of low plasma ghrelin may help minimize excess inflammatory response in these patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001546     DOI: 10.1007/s00595-012-0342-2

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  31 in total

1.  Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer.

Authors:  Nobuhiro Sato; Keisuke Koeda; Kenichiro Ikeda; Yusuke Kimura; Kiichi Aoki; Takeshi Iwaya; Yuji Akiyama; Kaoru Ishida; Kazuyoshi Saito; Shigeatsu Endo
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

2.  Soluble L-selectin levels predict survival in sepsis.

Authors:  Jakob B Seidelin; Ole H Nielsen; Jens Strøm
Journal:  Intensive Care Med       Date:  2002-09-21       Impact factor: 17.440

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  Clinical benefits of steroid therapy on surgical stress in patients with esophageal cancer.

Authors:  H Shimada; T Ochiai; S Okazumi; H Matsubara; Y Nabeya; Y Miyazawa; M Arima; Y Funami; H Hayashi; A Takeda; Y Gunji; T Suzuki; S Kobayashi
Journal:  Surgery       Date:  2000-11       Impact factor: 3.982

5.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Authors:  S M Opal; C J Fisher; J F Dhainaut; J L Vincent; R Brase; S F Lowry; J C Sadoff; G J Slotman; H Levy; R A Balk; M P Shelly; J P Pribble; J F LaBrecque; J Lookabaugh; H Donovan; H Dubin; R Baughman; J Norman; E DeMaria; K Matzel; E Abraham; M Seneff
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

6.  Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure.

Authors:  Noritoshi Nagaya; Junji Moriya; Yoshio Yasumura; Masaaki Uematsu; Fumiaki Ono; Wataru Shimizu; Kazuyuki Ueno; Masafumi Kitakaze; Kunio Miyatake; Kenji Kangawa
Journal:  Circulation       Date:  2004-11-29       Impact factor: 29.690

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality.

Authors:  Daryl O Schwenke; Takeshi Tokudome; Ichiro Kishimoto; Takeshi Horio; Mikiyasu Shirai; Patricia A Cragg; Kenji Kangawa
Journal:  Endocrinology       Date:  2008-07-03       Impact factor: 4.736

9.  Neutrophil elastase inhibitor (sivelestat) preserves antitumor immunity and reduces the inflammatory mediators associated with major surgery.

Authors:  Shintaro Akamoto; Keiichi Okano; Takanori Sano; Shinichi Yachida; Kunihiko Izuishi; Hisashi Usuki; Hisao Wakabayashi; Yasuyuki Suzuki
Journal:  Surg Today       Date:  2007-04-30       Impact factor: 2.549

10.  Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats.

Authors:  Rongqian Wu; Weifeng Dong; Mian Zhou; Fangming Zhang; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Am J Respir Crit Care Med       Date:  2007-07-12       Impact factor: 21.405

View more
  7 in total

Review 1.  Clinical application of ghrelin in the field of surgery.

Authors:  Shuji Takiguchi; Kohei Murakami; Yoshitomo Yanagimoto; Akihiro Takata; Yasuhiro Miyazaki; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Cancer Recurrence After Esophagectomy: Impact of Postoperative Infection in Propensity-Matched Cohorts.

Authors:  Vernissia Tam; James D Luketich; Daniel G Winger; Inderpal S Sarkaria; Ryan M Levy; Neil A Christie; Omar Awais; Manisha R Shende; Katie S Nason
Journal:  Ann Thorac Surg       Date:  2016-06-25       Impact factor: 4.330

Review 3.  Clinical application of ghrelin administration for gastric cancer patients undergoing gastrectomy.

Authors:  Shuji Takiguchi; Akihiro Takata; Kohei Murakami; Yasuhiro Miyazaki; Yoshitomo Yanagimoto; Yukinori Kurokawa; Tsuyoshi Takahashi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2013-09-20       Impact factor: 7.370

4.  Effects of ghrelin administration on the early postoperative inflammatory response after esophagectomy.

Authors:  Akihiro Takata; Shuji Takiguchi; Kohei Murakami; Yasuhiro Miyazaki; Hiroshi Miyata; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Masaki Mori; Kenji Kangawa; Yuichiro Doki
Journal:  Surg Today       Date:  2014-11-08       Impact factor: 2.549

Review 5.  Diverse and Complementary Effects of Ghrelin and Obestatin.

Authors:  Daniel Villarreal; Geetali Pradhan; Yu Zhou; Bingzhong Xue; Yuxiang Sun
Journal:  Biomolecules       Date:  2022-03-29

Review 6.  Cachexia in patients with oesophageal cancer.

Authors:  Poorna Anandavadivelan; Pernilla Lagergren
Journal:  Nat Rev Clin Oncol       Date:  2015-11-17       Impact factor: 66.675

7.  Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial.

Authors:  Yoshitomo Yanagimoto; Shuji Takiguchi; Yasuhiro Miyazaki; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Hiroshi Miyata; Kiyokazu Nakajima; Hiroshi Hosoda; Kenji Kangawa; Masaki Mori; Yuichiro Doki
Journal:  Br J Cancer       Date:  2016-06-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.